E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/31/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

S&P keeps Chiron on positive watch

Standard & Poor's said its ratings for Chiron Corp. remain on CreditWatch with positive implications. Ratings on watch include its BBB+ corporate credit and senior unsecured debt ratings.

On Monday, the company and its 42% owner, Novartis AG (AAA/stable/A-1+), agreed to a revised $5.1 billion definitive merger agreement, the agency said.

If the transaction is completed as expected in the first half of 2006, S&P said its ratings on Chiron's debt will be raised to AAA, unless the debt is retired.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.